<DOC>
	<DOCNO>NCT01937351</DOCNO>
	<brief_summary>A non-randomized , prospective , global clinical trial Avinger Pantheris System , atherectomy device provide directional visualization image adjunct fluoroscopy aid removal plaque diseased low extremity artery .</brief_summary>
	<brief_title>Evaluation Pantheris Optical Coherence Tomography Imaging Atherectomy System Use Peripheral Vasculature</brief_title>
	<detailed_description>The trial enroll 173 subject diagnosed peripheral arterial disease low extremities 20 site ( 3 international site ) , include 133 Intention Treat subject 2 additional Roll-In subject site ( 40 Roll-In subject total ) . The primary disease must locate reference vessel diameter ≥ 2.5 mm ≤ 7.0 mm . Trial success focus safety include rate major adverse event 6 month adjudicate Clinical Events Committee . Effectiveness evaluate use technical success , define percent target lesion residual diameter stenosis &lt; 50 % post-treatment Pantheris device alone assess Angiographic Core Lab .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Age ≥ 18 year old ; Subject candidate percutaneous intervention peripheral arterial disease leg ; Subject willing able give inform consent ; Documented symptomatic atherosclerotic peripheral arterial disease Rutherford Classification 25 ; Reference vessel lumen proximal target lesion ≥ 2.5 mm ≤ 7.0 mm diameter visual estimation ; Subject de novo target lesion ( ) stenosis &gt; 70 % visual estimation distal profunda femoral artery . No 2 lesion may treat Pantheris device ; Target lesion length ≤ 15 cm ( may two tandem lesion exceed 15cm total length ) ; Subject capable meeting requirement present followup clinic visit 30 day 6 month ; At least one patent tibial runoff vessel baseline . Subject pregnant breast feeding ; Rutherford Class 0 1 ( asymptomatic mild claudication ) ; Rutherford Class 6 ( critical limb ischemia ) ; Moderate severe calcification target lesion ; Acute ischemia and/or acute thrombosis SFAPopliteal segment ; Instent restenosis within target lesion ; Target lesion type stent graft ; Target lesion iliac artery ; Target lesion stenosis &lt; 70 % ; Subjects significant ( ≥70 % ) occlusive lesion proximal target lesion successfully treat index procedure ( upstream disease ) prior treatment target lesion ; Endovascular surgical procedure perform index limb less equal 30 day prior index procedure ; Planned endovascular surgical procedure 30 day index procedure ; Lesion contralateral limb require intervention index procedure within 30 day index procedure ; Subjects active systemic infection whether currently treat ; Subjects chronic hemodialysis creatinine level &gt; 2.0mg/dL ; Evidence history intracranial gastrointestinal bleeding , intracranial aneurysm , myocardial infarction stroke within past 2 month ; Evidence history aneurysmal target vessel within past 2 month ; History severe trauma , fracture , major surgery biopsy parenchymal organ within past 14 day ; Known allergy contrast agent medication use perform endovascular intervention adequately pretreated ; Subjects antiplatelet , anticoagulant , thrombolytic therapy contraindicate ; History heparininduced thrombocytopenia ( HIT ) ; Uncorrectable bleeding diathesis , platelet dysfunction , thrombocytopenia platelet count less 100,000/mm2 , know coagulopathy , INR &gt; 1.5 ; Any thrombolytic therapy within 2 week index procedure ; Any clinical and/or angiographic complication attribute use another device prior insertion study device subject ; Subjects legal guardian sign Informed Consent ; Subjects unwilling unable comply followup study requirement ; Participation study investigational device , medication , biologic agent within 30 day prior enrollment either cardiovascular study could , judgment investigator , affect result study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Atherectomy</keyword>
	<keyword>Optical Coherence Tomography</keyword>
	<keyword>Lumivascular</keyword>
</DOC>